A 26-Week Randomized Controlled Trial of Semaglutide Once Daily Versus Liraglutide and Placebo in Patients With Type 2 Diabetes Suboptimally Controlled on Diet and Exercise With or Without Metformin

Lingvay, I; Desouza, CV; Lalic, KS; Rose, L; Hansen, T; Zacho, J; Pieber, TR

Pieber, TR (reprint author), Med Univ Graz, Graz, Austria.

DIABETES CARE, 2018; 41 (9): 1926

Abstract

OBJECTIVETo investigate the efficacy and safety of once-daily semaglutide in comparison with once-daily liraglutide and placebo in patients with type ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索